Patent Assignment
Reel/Frame 043526/0977
Change of Name
Recorded: 2017-09-07
Pages: 2
Assignor
TEKMIRA PHARMACEUTICALS CORPORATION
Executed: 2015-07-31
Assignee
ARBUTUS BIOPHARMA CORPORATION
100-8900 GLENLYON PARKWAY, BURNABY, BRITISH COLUMBIA, V5J 5J8, CANADA
Covered Properties
(4)
Screening Method for Selected Amino Lipid-Containing Compositions
Application:
12/811,503 →
Publication:
US 2011/0097720
Screening Method for Selected Amino Lipid-Containing Compositions
Application:
13/460,963 →
Publication:
US 2012/0225434
Screening Method for Selected Amino Lipid-Containing Compositions
Application:
14/059,307 →
Publication:
US 2014/0295449
Screening Method for Selected Amino-Lipid-Containing Compositions
Application:
14/928,234 →
Publication:
US 2016/0274089
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 21, 2013
From: ALNYLAM PHARMACEUTICALS, INC.
To: TEKMIRA PHARMACEUTICALS CORPORATION
Reel/Frame 029852/0306 →
Assignment of Assignor's Interest
Sep 7, 2017
From: ALNYLAM PHARMACEUTICALS, INC.
To: TEKMIRA PHARMACEUTICALS CORPORATION
Reel/Frame 043526/0870 →
Merger and Change of Name
Jul 27, 2018
From: PROTIVA BIOTHERAPEUTICS INC.; ARBUTUS BIOPHARMA CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 046640/0764 →